Search Within

Rona Denit Yaeger

Formats
  1. Meeting Abstract (166)
  2. Journal Article (143)
  3. Review (7)
  4. Editorial (6)
  5. Research Letter (4)
  6. Book Section (1)
  7. Correspondence (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (329)
  2. Gastrointestinal Oncology Service (329)
  3. Solid Tumor Oncology Division (329)
  4. Center for Pancreatic Cancer Research (136)
  5. GSK Faculty (134)
  6. Department of Pathology and Laboratory Medicine (125)

More Groups

People
  1. Andrea Cercek Hanjis (95)
  2. Leonard Saltz (81)
  3. Jinru Shia (76)
  4. Martin Weiser (64)
  5. Zsofia Stadler (62)
  6. Julio Garcia Aguilar (61)

More People

Years
  1. 2025 (29)
  2. 2024 (41)
  3. 2023 (37)
  4. 2022 (39)
  5. 2021 (36)
  6. 2020 (28)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Annals of Oncology (37)
  3. Clinical Cancer Research (17)
  4. Cancer Research (15)
  5. Cancer Discovery (14)
  6. Nature Medicine (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (111)
  2. American Association for Cancer Research (51)
  3. Oxford University Press (48)
  4. Nature Publishing Group (26)
  5. Elsevier Inc. (19)
  6. Springer (10)

More Publishers

Results (329)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mismatch repair-deficient rectal cancer and resistance to neoadjuvant chemotherapy
    Journal Article

    Cercek, A.; Dos Santos Fernandes, G.; Roxburgh, C. S.; Ganesh, K.; Ng, S.; Sanchez-Vega, F.; Yaeger, R.; Segal, N. H.; Reidy-Lagunes, D. L.; Varghese, A. M.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Encorafenib plus cetuximab with or without binimetinib for BRAF V600E-mutant metastatic colorectal cancer: Quality-of-life results from a randomized, three-arm, phase III study versus the choice of either irinotecan or FOLFIRI plus cetuximab (BEACON CRC)
    Meeting Abstract

    Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H. S.; Yoshino, T.; Desai, J.; Ciardiello, F.; Loupakis, F.; Hong, Y. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic alterations in colitis-associated cancers in comparison to those found in sporadic colorectal cancer and present in precancerous dysplasia
    Meeting Abstract

    Chatila, W. K.; Walch, H. S.; Benhamida, J.; Hechtman, J. F.; Barriga, F. M.; Kundra, R.; Ismalgeci, D.; Miller, V. A.; Ganesh, K.; Faleck, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic characterization of rectal cancer and molecular determinants of response to neoadjuvant chemoradiotherapy
    Meeting Abstract

    Chatila, W. K.; Marco, M.; Qu, X.; Walch, H. S.; Luthra, A.; Chen, C. T.; Kundra, R.; Schultz, N.; Yaeger, R.; Smith, J. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • BRAF-mutant transcriptional subtypes predict outcome of combined BRAF, MEK, and EGFR blockade with dabrafenib, trametinib, and panitumumab in patients with colorectal cancer
    Journal Article

    Middleton, G.; Yang, Y.; Campbell, C. D.; André, T.; Atreya, C. E.; Schellens, J. H. M.; Yoshino, T.; Bendell, J. C.; Hollebecque, A.; McRee, A. J.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes
    Journal Article

    Hechtman, J. F.; Rana, S.; Middha, S.; Stadler, Z. K.; Latham, A.; Benayed, R.; Soslow, R.; Ladanyi, M.; Yaeger, R.; Zehir, A.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Overcoming adaptive resistance to KRAS inhibitors through vertical pathway targeting
    Editorial

    Yaeger, R.; Solit, D. B.
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • BEACON CRC: A randomized, phase 3 study of encorafenib (ENCO) and cetuximab (CETUX) with or without binimetinib (BiNI) vs. choice of either irinotecan or folfiri plus cetux in BRAF V600E-mutant metastatic colorectal cancer (mCRC)
    Meeting Abstract

    Vogel, A.; Hegewisch-Becker, S.; Prager, G.; Folprecht, G.; Stahl, M.; Kopetz, S.; Grothey, A.; van Cutsetn, E.; Yaeger, R.; Wasan, H.; more...
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Coaltered Ras/B-raf and TP53 is associated with extremes of survivorship and distinct patterns of metastasis in patients with metastatic colorectal cancer
    Journal Article

    Datta, J.; Smith, J. J.; Chatila, W. K.; McAuliffe, J. C.; Kandoth, C.; Vakiani, E.; Frankel, T. L.; Ganesh, K.; Wasserman, I.; Lipsyc-Sharf, M.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Is hepatectomy justified for BRAF mutant colorectal liver metastases?: A multi-institutional analysis of 1497 patients
    Journal Article

    Gagnière, J.; Dupré, A.; Gholami, S. S.; Pezet, D.; Boerner, T.; Gönen, M.; Kingham, T. P.; Allen, P. J.; Balachandran, V. P.; De Matteo, R. P.; more...
    Annals of Surgery (2020)

    Fulltext@MSK | Save